$NTI $0.095 into the blueMonster range, now with decent end of range volume starting to come in = no reason to look back.
Now, its time for a decent run
Holding
Long
Neurotech International Ltd.
No trades
No trades
Compare with Neurotech International Ltd.
−0.005 AUD
−6.54 M AUD
0.00 AUD
1.50 B
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
Company info
Sector
Industry
Website
Headquarters
Melbourne
Founded
2016
IPO date
Nov 4, 2016
ISIN
AU000000NTI9
FIGI
BBG00DSXRN99
Identifiers
ISIN AU000000NTI9
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.
Long
$NTI NTI
--1 year accumulation/consolidation range
--Potential bull pennant forming.
--Hidden Weekly divergence
watch list for now.. looking for a break in direction A or B what direction do you have and why ??
-Landmark study into paediatric ASD (autism spectrum disorder) has now progressed to the t
Long
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of NTI is 0.014 AUD — it hasn't changed in the past 24 hours. Watch Neurotech International Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange Neurotech International Ltd. stocks are traded under the ticker NTI.
NTI stock has fallen by −6.67% compared to the previous week, the last month showed zero change in price, over the last year Neurotech International Ltd. has showed a −26.32% decrease.
NTI stock is 0.00% volatile and has beta coefficient of 0.99. Track Neurotech International Ltd. stock price on the chart and check out the list of the most volatile stocks — is Neurotech International Ltd. there?
Yes, you can track Neurotech International Ltd. financials in yearly and quarterly reports right on TradingView.
Neurotech International Ltd. is going to release the next earnings report on Mar 2, 2027. Keep track of upcoming events with our Earnings Calendar.
NTI net income for the last half-year is −5.84 M AUD, while the previous report showed −696.50 K AUD of net income which accounts for 0.00% change. Track more Neurotech International Ltd. financial stats to get the full picture.
No, NTI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NTI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Neurotech International Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Neurotech International Ltd. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Neurotech International Ltd. stock shows the sell signal. See more of Neurotech International Ltd. technicals for a more comprehensive analysis.